Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stem Cell Research

  Free Subscription


Articles published in Transfusion

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    May 2018
  1. AHN H, Tay J, Shea B, Hutton B, et al
    Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Transfusion. 2018 May 16. doi: 10.1111/trf.14656.
    PubMed     Text format     Abstract available


    April 2018
  2. NIITTYVUOPIO R, Juvonen E, Heiskanen J, Lindstrom V, et al
    Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a single-center experience.
    Transfusion. 2018 Apr 29. doi: 10.1111/trf.14649.
    PubMed     Text format     Abstract available


  3. MINAKAWA K, Ohto H, Yasuda H, Saito S, et al
    Efficacy of D- red blood cell transfusion and rituximab therapy in autoimmune hemolytic anemia with anti-D and panreactive autoantibodies arising after hematopoietic stem cell transplant.
    Transfusion. 2018 Apr 17. doi: 10.1111/trf.14634.
    PubMed     Text format     Abstract available


  4. CASTRO G, Merkel PA, Giclas HE, Gibula A, et al
    Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.
    Transfusion. 2018 Apr 2. doi: 10.1111/trf.14589.
    PubMed     Text format     Abstract available


    March 2018
  5. RUSSELL AL, Lefavor R, Durand N, Glover L, et al
    Modifiers of mesenchymal stem cell quantity and quality.
    Transfusion. 2018 Mar 26. doi: 10.1111/trf.14597.
    PubMed     Text format     Abstract available


  6. BOJANIC I, Mravak Stipetic M, Pulanic D, Desnica L, et al
    Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft-versus-host disease.
    Transfusion. 2018 Mar 14. doi: 10.1111/trf.14594.
    PubMed     Text format     Abstract available


  7. WANG T, Remberger M, Axdorph Nygell U, Sundin M, et al
    Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors.
    Transfusion. 2018 Mar 13. doi: 10.1111/trf.14579.
    PubMed     Text format     Abstract available


    February 2018
  8. MARCHESI F, Vacca M, Giannarelli D, Ipsevich F, et al
    Lenograstim 5 microg/kg is not superior to biosimilar filgrastim 10 microg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14533.
    PubMed     Text format     Abstract available


  9. WOREL N, Lehner E, Fuhrer H, Kalhs P, et al
    Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14506.
    PubMed     Text format     Abstract available


    December 2017
  10. ZHU J, Huang H, Chen H, Zhang X, et al
    Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study.
    Transfusion. 2017 Dec 13. doi: 10.1111/trf.14426.
    PubMed     Text format     Abstract available


  11. VILLA CH, Porturas T, Sell M, Wall M, et al
    Rapid prediction of stem cell mobilization using volume and conductivity data from automated hematology analyzers.
    Transfusion. 2017 Dec 11. doi: 10.1111/trf.14449.
    PubMed     Text format     Abstract available


  12. PIERCE J, Benedetti E, Preslar A, Jacobson P, et al
    Comparative analyses of industrial-scale human platelet lysate preparations.
    Transfusion. 2017;57:2858-2869.
    PubMed     Text format     Abstract available


    November 2017
  13. PIERELLI L, Bosi A, Olivieri A
    "Best practice" for extracorporeal photopheresis in acute and chronic graft-versus-host disease by Societa' Italiana di Emaferesi and Manipolazione Cellulare and Gruppo Italiano Trapianto Midollo Osseo: a national survey to ascertain its degree of app
    Transfusion. 2017 Nov 13. doi: 10.1111/trf.14400.
    PubMed     Text format     Abstract available


  14. SOURI M, Nikougoftar Zarif M, Rasouli M, Golzadeh K, et al
    Comparison of human umbilical cord blood processing with or without hydroxyethyl starch.
    Transfusion. 2017;57:2758-2766.
    PubMed     Text format     Abstract available


    September 2017
  15. FINGRUT W, Parmar S, Cuperfain A, Rikhraj K, et al
    The Stem Cell Club: a model for unrelated stem cell donor recruitment.
    Transfusion. 2017 Sep 24. doi: 10.1111/trf.14327.
    PubMed     Text format     Abstract available


    July 2017
  16. ALBANO MS, Ciubotariu R, Dobrila L, Tarnawski M, et al
    Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency.
    Transfusion. 2017 Jul 31. doi: 10.1111/trf.14257.
    PubMed     Text format     Abstract available


  17. BAILEN R, Kwon M, Perez-Corral AM, Pascual C, et al
    Transient hemolysis due to anti-D and anti-A1 produced by engrafted donor's lymphocytes after allogeneic unmanipulated haploidentical hematopoietic stem cell transplantation.
    Transfusion. 2017 Jul 13. doi: 10.1111/trf.14232.
    PubMed     Text format     Abstract available


  18. PARTANEN A, Valtola J, Silvennoinen R, Ropponen A, et al
    Impact of lenalidomide-based induction therapy on the mobilization of CD34+ cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.
    Transfusion. 2017 Jul 5. doi: 10.1111/trf.14220.
    PubMed     Text format     Abstract available


  19. LEAHY MF, Trentino KM, May C, Swain SG, et al
    Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program.
    Transfusion. 2017 Jul 3. doi: 10.1111/trf.14191.
    PubMed     Text format     Abstract available


    June 2017
  20. PICCIN A, Rebulla P, Pupella S, Tagnin M, et al
    Impressive tissue regeneration of severe oral mucositis post stem cell transplantation using cord blood platelet gel.
    Transfusion. 2017 Jun 27. doi: 10.1111/trf.14205.
    PubMed     Text format     Abstract available


  21. LISENKO K, Baertsch MA, Meiser R, Pavel P, et al
    Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.
    Transfusion. 2017 Jun 26. doi: 10.1111/trf.14211.
    PubMed     Text format     Abstract available


  22. KAPLAN A, Sackett K, Sumstad D, Kadidlo D, et al
    Impact of starting material (fresh versus cryopreserved marrow) on mesenchymal stem cell culture.
    Transfusion. 2017 Jun 26. doi: 10.1111/trf.14192.
    PubMed     Text format     Abstract available


  23. GROMME M, Russcher H, Braakman E, Klinkspoor JH, et al
    Multicenter study to evaluate a new enumeration method for hematopoietic stem cell collection management.
    Transfusion. 2017 Jun 26. doi: 10.1111/trf.14183.
    PubMed     Text format     Abstract available


  24. WOREL N, Frank N, Frech C, Fritsch G, et al
    Influence of plerixafor on the mobilization of CD34+ cell subpopulations and lymphocyte subtypes.
    Transfusion. 2017 Jun 5. doi: 10.1111/trf.14182.
    PubMed     Text format     Abstract available


    March 2017
  25. COOLING L, Roxbury K, Hoffmann S, DeBusscher J, et al
    Use of allogeneic apheresis stem cell products as an interlaboratory proficiency challenge.
    Transfusion. 2017 Mar 28. doi: 10.1111/trf.14107.
    PubMed     Text format     Abstract available


  26. OTROCK ZK, Sempek DS, Carey S, Grossman BJ, et al
    Adverse events of cryopreserved hematopoietic stem cell infusions in adults: a single-center observational study.
    Transfusion. 2017 Mar 16. doi: 10.1111/trf.14072.
    PubMed     Text format     Abstract available


  27. LEBERFINGER DL, Badman KL, Roig JM, Loos T, et al
    Improved planning of leukapheresis endpoint with customized prediction algorithm: minimizing collection days, volume of blood processed, procedure time, and citrate toxicity.
    Transfusion. 2017;57:685-693.
    PubMed     Text format     Abstract available


    February 2017
  28. GE I, Saliba RM, Maadani F, Popat UR, et al
    Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma.
    Transfusion. 2017 Feb 10. doi: 10.1111/trf.14016.
    PubMed     Text format     Abstract available


  29. MATHUR G, Mott SL, Collins L, Nelson GA, et al
    Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection.
    Transfusion. 2017 Feb 1. doi: 10.1111/trf.14022.
    PubMed     Text format     Abstract available


    December 2016
  30. CONSTANTINOU VC, Bouinta A, Karponi G, Zervou F, et al
    Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with beta-thalassemia major.
    Transfusion. 2016 Dec 17. doi: 10.1111/trf.13951.
    PubMed     Text format     Abstract available


    November 2016
  31. SCHRIMPF C, Wrede C, Glage S, Hegermann J, et al
    Differentiation of induced pluripotent stem cell-derived neutrophil granulocytes from common marmoset monkey (Callithrix jacchus).
    Transfusion. 2016 Nov 25. doi: 10.1111/trf.13909.
    PubMed     Text format     Abstract available


  32. SPOERL S, Peter R, Wascher D, Gotze K, et al
    Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis.
    Transfusion. 2016 Nov 18. doi: 10.1111/trf.13883.
    PubMed     Text format     Abstract available


  33. GERBY S, Attebi E, Vlaski M, Ivanovic Z, et al
    A new clinical-scale serum-free xeno-free medium efficient in ex vivo amplification of mesenchymal stromal cells does not support mesenchymal stem cells.
    Transfusion. 2016 Nov 10. doi: 10.1111/trf.13902.
    PubMed     Text format     Abstract available


    October 2016
  34. YUAN S, Wang S
    How do we mobilize and collect autologous peripheral blood stem cells?
    Transfusion. 2016 Oct 12. doi: 10.1111/trf.13868.
    PubMed     Text format     Abstract available


  35. EVEN-OR E, Eden-Walker A, Di Mola M, McDougall E, et al
    Comparison of two apheresis systems for autologous stem cell collections in pediatric oncology patients.
    Transfusion. 2016 Oct 3. doi: 10.1111/trf.13859.
    PubMed     Text format     Abstract available


    September 2016
  36. BECKER P, Schwebig A, Brauninger S, Bialleck H, et al
    Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performance.
    Transfusion. 2016 Sep 16. doi: 10.1111/trf.13853.
    PubMed     Text format     Abstract available


  37. CANCELAS JA, Scott EP, Bill JR
    Continuous CD34+ cell collection by a new device is safe and more efficient than by a standard collection procedure: results of a two-center, crossover, randomized trial.
    Transfusion. 2016 Sep 2. doi: 10.1111/trf.13769.
    PubMed     Text format     Abstract available


    August 2016
  38. IKEDA K, Minakawa K, Muroi K, Fujiwara SI, et al
    Prospective randomized and crossover comparison of two apheresis machines for peripheral blood stem cell collection: a multicenter study.
    Transfusion. 2016 Aug 29. doi: 10.1111/trf.13777.
    PubMed     Text format     Abstract available


  39. LI Y, Li J, Reeves HM, Reyes R, et al
    Comparison of two apheresis systems during hematopoietic progenitor stem cell collections at a tertiary medical center.
    Transfusion. 2016 Aug 3. doi: 10.1111/trf.13754.
    PubMed     Text format     Abstract available


  40. AVDIC A, Tucker S, Evans R, Smith A, et al
    Comparing the ratio of mean red blood cell transfusion episode rate of 1 unit versus 2 units in hematopoietic stem cell transplant patients.
    Transfusion. 2016 Aug 2. doi: 10.1111/trf.13708.
    PubMed     Text format     Abstract available


    July 2016
  41. HAUSMANN A, Fischer N, Breitkopf S, Menne F, et al
    Severe motor aphasia after reinfusion of cryopreserved autologous stem cells after myeloablative conditioning.
    Transfusion. 2016 Jul 27. doi: 10.1111/trf.13744.
    PubMed     Text format     Abstract available


    June 2016
  42. FIALA MA, Park S, Slade M, DiPersio JF, et al
    Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantation.
    Transfusion. 2016 Jun 17. doi: 10.1111/trf.13688.
    PubMed     Text format     Abstract available


    May 2016
  43. THURIK FF, Page-Christiaens GC, Ait Soussan A, Ligthart PC, et al
    Fetal RHD genotyping after bone marrow transplantation.
    Transfusion. 2016 May 30. doi: 10.1111/trf.13669.
    PubMed     Text format     Abstract available


  44. WU CY, Chiou TJ, Liu CY, Lin FC, et al
    Decision-tree algorithm for optimized hematopoietic progenitor cell-based predictions in peripheral blood stem cell mobilization.
    Transfusion. 2016 May 27. doi: 10.1111/trf.13666.
    PubMed     Text format     Abstract available


  45. KRESNIK PK, Krasna M, Rozman P, Vrtovec B, et al
    Collection and immunoselection of CD34+ cells: the impact of age, sex, and diabetes in patients with chronic heart failure.
    Transfusion. 2016 May 17. doi: 10.1111/trf.13646.
    PubMed     Text format     Abstract available


    April 2016
  46. MAYS R, Deans R
    Adult adherent cell therapy for ischemic stroke: clinical results and development experience using MultiStem.
    Transfusion. 2016;56:6S-8S.
    PubMed     Text format    


  47. HEMATTI P
    Characterization of mesenchymal stromal cells: potency assay development.
    Transfusion. 2016;56:32S-5S.
    PubMed     Text format     Abstract available


  48. SCHAFER R, Bieback K
    Characterization of mesenchymal stem or stromal cells: tissue sources, heterogeneity, and function.
    Transfusion. 2016;56:2S-5S.
    PubMed     Text format    


  49. NGUYEN K
    Process automation in manufacturing of mesenchymal stromal cells.
    Transfusion. 2016;56:26S-8S.
    PubMed     Text format    


  50. KAMANI NR
    Mesenchymal stromal cells: are they ready for prime time?
    Transfusion. 2016;56:1S.
    PubMed     Text format    


  51. MCKENNA D
    Challenges in the cGMP manufacturing of MSCs for multicenter academia trials.
    Transfusion. 2016;56:18S-9S.
    PubMed     Text format    


  52. NOLTA JA
    "Next-generation" mesenchymal stem or stromal cells for the in vivo delivery of bioactive factors: progressing toward the clinic.
    Transfusion. 2016;56:15S-7S.
    PubMed     Text format    


  53. LEE SA, Kim JY, Choi Y, Kim Y, et al
    Application of mutant JAK2V617F for in vitro generation of red blood cells.
    Transfusion. 2016;56:837-43.
    PubMed     Text format     Abstract available


    February 2016
  54. AVECILLA ST, Marionneaux SM, Leiva TD, Tonon JA, et al
    Comparison of manual hematocrit determinations versus automated methods for hematopoietic progenitor cell apheresis products.
    Transfusion. 2016;56:528-32.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: